Discordant sestamibi uptake in synchronous parathyroid carcinoma and adenoma. [PDF]
Wang Q, Zhou X, Lu R, Shen H, Wei B.
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source
Effectiveness of Contrast-Enhanced Spectral Mammography Following Contrast-Enhanced Computed Tomography in Breast Cancer Diagnosis. [PDF]
Tasdelen I, Gunkan A, Soylu FN.
europepmc +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Deep Learning-Assisted Localization of Cystic Lesions and Benign Tumors in the Maxillofacial Region Using Panoramic Radiographs: A Preliminary Feasibility Study. [PDF]
Lien KH +9 more
europepmc +1 more source
A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling +16 more
wiley +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Computed Tomography Findings of Pulmonary Lymphoma in a Dog and Two Cats. [PDF]
Tanaka T +4 more
europepmc +1 more source
La péripneumonie bovine : le lymphotropisme de Mycoplasma mycoides. I. Données histo-pathologiques et physiologiques [PDF]
Mémery, Georges +2 more
core
Giant Vulvar Vascular Lesion in Pregnancy: A Case Report. [PDF]
Jin Y, Gao J, Luo L, Wu Y.
europepmc +1 more source

